SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001062993-21-003594
Filing Date
2021-04-13
Accepted
2021-04-13 14:05:48
Documents
1
Group Members
ADVENT LIFE SCIENCES FUND II LPKAASIM MAHMOODRAJESH PAREKHSHAHZAD MALIK

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D formsc13d.htm SC 13D 102500
  Complete submission text file 0001062993-21-003594.txt   104339
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-56243 | Film No.: 21822770
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND 44 (0) 207 932 2120
Advent Life Sciences LLP (Filed by) CIK: 0001601364 (see all company filings)

IRS No.: 000000000
Type: SC 13D